Navigation Links
Drug Firm on the Threshold of Developing Dengue Vaccine

A giant pharmaceutical firm is close to developing the world's first vaccine against dengue fever as Singapore and neighbouring countries battle outbreaks, a news report said Friday.

Clinical tests on up to 3,000 people will begin by early next year in Thailand, said Jean Stephenne, GlaxoSmithKline Biologicals president.

"We've been working on the dengue vaccine with the US Army for 10 years, more or less," The Straits Times quoted Stephenne as saying.

The Thai trials will be part of the second phase of the process.

The vaccine was tested on 500 people in the United States during the first phase and proved safe and effective, Stephenne said. Once the Thai trials are completed, the vaccine will move to the final stage to test its effectiveness in other parts of the world, including Singapore.

Cases of the Aedes mosquito-carried virus have reached epidemic levels twice in the city-state since June. There have been 3,597 cases and three deaths since the start of the year.

Intermittent rain and warm weather have been blamed for the onslaught of mosquito breeding.

Stephenne said that another key factor is that the virus has four variations.

"We have to prove the vaccine will be safe for everyone, which means both children and adults," Stephenne told the newspaper.

The company is aiming to have the vaccine on the market in about five years. By that time, Stephenne estimates that between $500 million to $1 billion will have been spent on research and development.


'"/>




Page: 1

Related medicine news :

1. Calcium Supplements May Not Be Useful After A Certain Threshold Is Achieved
2. Risk Of Developing Arthritis
3. Developing HIV fighter
4. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. Men Who at Risk Of Developing Prostate Cancer
7. Identifying The Risks Of Developing Schizophrenia
8. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
9. Cancer Patients At A Greater Risk Of Developing Blood Clots
10. Young Smokers at Increased Risk Of Developing a Heart Attack
11. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... ... May 06, 2016 , ... The ... digital-based Zika education initiative in Puerto Rico. Radio messages set to debut on ... from physicians and pharmacists about ways to protect themselves and their unborn children ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... master charity program created to support and assist the people of their local ... closely with nonprofit organizations and community leaders. Their desire is to bring awareness ...
(Date:5/6/2016)... ... ... US Sports Camps has collaborated with State Rugby Organization (SRO), Rugby Oregon, ... Employing world-class rugby figures, including former Team USA players and college coaches, this program ... match play, fitness and more. , “US Sports Camps is honored to be working ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... reduce fat areas around the body, is the most popular among body sculpting ... released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical director of ...
(Date:5/6/2016)... ... ... From the Speaker Podium to the Exhibit Floor at Booth#514, Worldwide Leading Contact ... Engagement at SpeechTek 2016 Event, taking place May 23-25 at the Omni Shoreham in ... on “5 Customer Engagement Strategies to improve Customer Satisfaction in your Contact Center” on ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ALBANY, New York , May 4, 2016 /PRNewswire/ ... published by Transparency Market Research entitled "Brain Computer Interface Market ... Forecast 2016 - 2024," the  global brain computer interface (BCI) ... bn by 2024. The market is estimated to expand ... period from 2016 to 2024. A BCI ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
(Date:5/4/2016)... 2016 Research and ... Acute Ischemic Stroke Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Stroke Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Ischemic Stroke epidemiology, Acute ...
Breaking Medicine Technology: